+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis



Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis



Plos One 9(1): E87019



Several observational studies have shown that statin use may modify the risk of haematological malignancies. To quantify the association between statin use and risk for haematological malignancies, we performed a detailed meta-analysis of published studies regarding this subject. We conducted a systematic search of multiple databases including PubMed, Embase, and Cochrane Library Central database up to July 2013. Fixed-effect and random-effect models were used to estimate summary relative risks (RR) and the corresponding 95% confidence intervals (CIs). Potential sources of heterogeneity were detected by meta-regression. Subgroup analyses and sensitivity analysis were also performed. A total of 20 eligible studies (ten case-control studies, four cohort studies, and six RCTs) reporting 1,139,584 subjects and 15,297 haematological malignancies cases were included. Meta-analysis showed that statin use was associated with a statistically significant 19% reduction in haematological malignancies incidence (RR = 0.81, 95% CI [0.70, 0.92]). During subgroup analyses, statin use was associated with a significantly reduced risk of haematological malignancies among observational studies (RR = 0.79, 95% CI [0.67, 0.93]), but not among RCTs (RR = 0.92, 95% CI [0.77, 1.09]). Based on this comprehensive meta-analysis, statin use may have chemopreventive effects against haematological malignancies. More studies, especially definitive, randomized chemoprevention trials are needed to confirm this association.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911508

Download citation: RISBibTeXText

PMID: 24498014

DOI: 10.1371/journal.pone.0087019


Related references

Statin use is associated to a reduced risk of pancreatic cancer: A meta-analysis. Digestive and Liver Disease 2018, 2018

Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis. European Respiratory Journal 50(2), 2018

Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies. British Journal of Clinical Pharmacology 64(3): 255-262, 2007

Reduced Risk of Barrett's Esophagus in Statin Users: Case-Control Study and Meta-Analysis. Digestive Diseases and Sciences 61(1): 238-246, 2016

Comparative meta-analysis of 6 statin and 9 non-statin coronary regression trials Evidence that cholesterol lowering is the key to outcomes. Circulation 94(8 SUPPL ): I579, 1996

No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis. Diabetologia 52(12): 2507-2512, 2010

Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis. Lupus 23(3): 284-292, 2014

Reduced intensity conditioning unrelated donor transplantation for very high risk haematological malignancies A single centre experience. Blood 102(11): 483a-484a, November 16, 2003

Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis. Plos One 10(4): E0124105, 2016

Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis. American Journal of Medicine 125(11): 1111-1123, 2013

Association of the PTEN IVS4 (rs3830675) gene polymorphism with reduced risk of cancer: evidence from a meta-analysis. Asian Pacific Journal of Cancer Prevention 16(3): 897-902, 2015

Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. British Journal of Haematology 131(1): 22-28, 2005

Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies. American Journal of Gastroenterology 103(10): 2646-2651, 2008

Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in patients with haematological and solid malignancies: protocol for a systematic review and meta-analysis. Bmj Open 7(12): E019321, 2018

Statin use and risk of fracture: a meta-analysis. International Journal of Clinical and Experimental Medicine 8(5): 8269-8275, 2015